Investigating the effect of propolis mouthwash in the prevention and treatment of mucosal inflammation caused by radiation therapy in head and neck cancers.

Number of pages: 125 File Format: word File Code: 31920
Year: 2011 University Degree: Master's degree Category: Medical Sciences
  • Part of the Content
  • Contents & Resources
  • Summary of Investigating the effect of propolis mouthwash in the prevention and treatment of mucosal inflammation caused by radiation therapy in head and neck cancers.

    Dissertation to receive a specialized doctorate degree in the field of oral diseases

    Abstract:

    Mucositis or mucosal inflammation is one of the early side effects of radiation therapy, which can cause ulcers in the oral mucosa and sometimes the inability to eat despite common treatments. Therefore, the use of compounds with a pleasant and acceptable smell and taste and with minimal side effects on the tissues of the mouth and teeth and at a reasonable cost and can be produced from natural resources within the country is completely logical and justified.

    Materials and methods: In a double-blind pilot study of a clinical trial, 20 patients in need of radiation therapy for the treatment of head and neck cancer were randomly selected into two groups of cases and controls. In the case group, 15 ml of propolis and in the control group, 20 ml of placebo (placebo) were administered in the form of 3 doses of mouthwash for 5 minutes, which were then swallowed, and the patients were evaluated every other day to check the incidence rate, mucositis and its progress or improvement through the NCI-CTC scale and dry mouth with the relevant criteria. The results were analyzed with the help of T-Test, Man Whitney, Chi Square and Fridman tests.

    Findings: In the case group, the intensity of mucositis in all sessions was significantly less than the control group, and the patients using propolis for 3 weeks, which was longer than the control group, had no lesions. Except for the fourth week, there was no significant difference between the two groups in terms of dry mouth. No special complications caused by the use of propolis were observed in the patients.

    Conclusion: According to the results of this pilot study, propolis mouthwash has preventive and therapeutic properties on mucosal inflammation caused by radiation therapy in head and neck cancers and can be used in the prevention and treatment of mucositis.

    Keywords: propolis, mucositis, radiotherapy, cancer

    Introduction:

    Every year, millions of people around the world experience cancer or malignancy. do Cancers are the second cause of death in developed countries (1). Head and neck malignancies are among the most common cancers in humans that involve many anatomical points of the head and neck. Oropharyngeal cancers are more common in developing countries. (2,3) The goal of treating cancer patients is to cure the disease definitively and improve the patient's quality of life during the disease. The treatment of head and neck cancers in the last three decades has undergone many changes in all three types of treatment, surgery, radiation therapy and chemotherapy, but on the other hand, more use of chemotherapy and radiation therapy has led to an increase in many complications caused by these treatments, including mucositis or inflammation of the oral mucosa. (4) The amount of problems caused by radiation therapy depends on the type, dose and method of treatment. Oral and pharyngeal mucosa causes inflammation of the epithelium, especially in the second and third week. Severe mucositis appears with sores in the mouth and throat and very painful swallowing, which can even cause the treatment to be stopped due to a decrease in the quality of life. Also, mucositis may cause problems during treatment, such as incomplete treatment due to the patient's intolerance, weight loss, eating disorders and the need to take multiple medications. (7) These lesions, which are caused by the local effect of ionizing radiation on the oral mucosa, can differ from one disease to another based on risk factors such as patients' age, gender, oral health status, dose or amount of radiation and radiation therapy technique, having a specific underlying disease or smoking addiction (7).. Various methods have been considered for the treatment of this condition, but unfortunately none of them have been superior to the others.

    The incidence and severity of oral mucosal inflammation have been mentioned differently in the studies. These differences are due to the characteristics of the patients, the type of malignancy, drug regimens and treatment protocol. In general, the prevalence of this complication has been reported from 20 to 90% according to the type of treatment, and it occurs on average in 40% of cases. With inflammation of the oral mucosa, the risk of infection increases in the body of patients. (6,7)

    The oral environment is rich in all kinds of bacteria and fungi, and the oral mucosa acts as a physical barrier to prevent the pathogenicity of these factors. With the creation of ulcers in the mouth and the disintegration of the mucosa, the possibility of the invasion of opportunistic pathogens and the risk of secondary infections increases. At least half of those treated with a dose of 60 to 70 Gy in 6 to 7 weeks develop Grade 3 mucositis. (6) Cancer is a disease characterized by the uncontrolled proliferation of abnormal neoplastic cells. From:

    1 - Genetic and acquired mutations such as cigarette smoke and alcohol

    2 - Chromosomal disorders

    3 - The presence of oncogenic factors

    4 - Using immunosuppressive drugs or suffering from immunosuppressive diseases due to the reduction of Natural Killer cells that directly affect It affects cancer cells. At least 3 to 6 somatic mutations are required to transform a normal cell into a cancer cell. (7)

    Clinical manifestations of head and neck cancers are usually as:

    1 - Palpable mass

    2 - Color change of the skin or mucous membrane that are exposed

    3 - Increase in the volume of lymph nodes

    4- Disturbances in the functioning of organs have been seen.

    head and neck cancers

    About 2.9% of the new diagnosed cancers include types of head and neck cancers, and one third of these cases occur in women, except Salivary and nasopharyngeal tumors. Other cases usually occur after the age of 40. Smoking, alcohol and viruses such as human papilloma are the main risk factors. Most head and neck cancers originate from the epithelium, the most common of which is squamous cell tumor [1] (SCC). (8)

    Cancer treatments

    Generally, the basis of treatment for all cancers includes surgery, radiation therapy, chemotherapy, and hormonal drugs and possibly bone marrow transplantation, which inevitably exposes the patient to many complications. (7)

    Radiotherapy of the head and neck

    Radiotherapy alone is used in the treatment of radiation-sensitive malignancies such as lymphoma or Kaposi's sarcoma. Some cancers, such as epithelial cancers of the gastrointestinal tract, including the oral cavity, are moderately radiosensitive, in these areas, radiation therapy alone is used in tumors with a diameter of 3 cm or less and inoperable tumors, due to their serious or Systemic diseases preventing the use of anesthesia. (9)

    Ionizing radiation is performed as an external beam or direct electron radiation to the tumor or by local implantation (brachytherapy) of radioactive needles made of cesium, radium, gold, palladium or other metals that emit x-rays or gamma. In most radiation treatments of the head and neck, the total dose is from 50 to 80 Gy, which is done in fractions of 10 Gy per week for five weeks and 2 Gy daily in a period of five days per week.

  • Contents & References of Investigating the effect of propolis mouthwash in the prevention and treatment of mucosal inflammation caused by radiation therapy in head and neck cancers.

    List:

    None.  

    Source:

    1- Little JW, Falace DA, Miller CS, Rhodus NL.  Dental management of the medically compromised patients. 7th ed. St. Louis: Mosby Elsevier; 2008. 2-Stewart BW, Kleihues P. World Cancer Report, 1st ed. International Agency for research on cancer, Lyon WHO 2003.

    3-Petersen PE. The World Oral Health Report 2003: continuous improvement of oral health in the 21st century - the approach of WHO Global Oral Health Programme. Community Dent. Oral Epidemiol 2003; 31(suppl.1):3-24.

    4-Scully C, Epstein JB. Oral health care for the cancer patient. Oral Oncol Eur J Cancer 1996; 32 B:281-292.

    5-Vissink A, Burlage FR, Spijkervet FKL, Jansmal J, Coppes RP. Prevention & treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003; 14(3):213-225.

    6- Suemaru K, Cui R, Li B, Watanabe S, Okihara K, Hashimoto K, Yamada H, Araki H. Topical application of royal jelly has a healing effect for 5-fluorouracil-induced experimental oral mucositis in hamsters. Methods Find Exp Clin Pharmacol. 2008 March; 30(2):103-6.

    7-Berger Ann M, Fall-Dickson Jane M. Oral complications. In: Vincent T DeVita, editors. Devita Principles and practice of oncology. 7th ed. Philadelphia: Lippincott Williams & Wilkins. 2008

    8- Greenberg MS, Glick M, Ship JA. Burket's Oral Medicine, 11 th Ed. Canada, Bedecker, 2008.

    9- Sedano H. Oral complications during cancer treatment. 1993 Available at: [www. Dent. UCLA. edu/Pic/pic/menbrs/cancer].

    10- Hall Ej. Radiobiology for the Radiobiologist. 5 th. Philadelphia, Lippincott Williams & Wilkins, 2000; P: 5-16,397-418, 49-491

    11- Fajardo LF. Morphology of radiation effect on normal tissue. In: Perez C, Brady L. Principles and Practice of Radiation Oncology. 3rd.Philadelphia, Lippin Cott-Raven, 2008; P: 87.

    12- Mundt A, Rieske J, Weichsellbaum R. Physical and biological basis of radiation oncology. In: Bast R, Kuff D, Pollock R, Weichselbaum R, Holland J, Frei E. Cancer medicine. 5th. Hamilton, B.C. Decker Inc., 2000; P: 456.

    13- Andrew N, Griffths C. Dental Complications of head & neck Radiotherapy Part 1. Australian Dental Journal 2001; 46:(2): 88-94.

    14- Rodney H, McBride Wh. Biological basis of radiation therapy. In: Perez C, Brady L. Principle & Practice of Radiation Oncology. 3rd. Philadelphia, Lippincott-Raven, 1998; P: 79.

    15-Motallebnejad M, Akram S, Moghadamnia A, Moulana Z, Omidi S. The Effect of Topical Application of Pure Honey on Radiation-induced Mucositis: A Randomized Clinical Trial. J Contemp Dent Pract 2008 March; (9)3:040-047.

    16- Peterson D, Schubert M. Oral Toxicity. In: Perry MC. The Chemotherapy Source Book. 3rd. Philadelphia, Lippincott Williams & Wilkins, 2001; P: 406-423.

    17- Delavarian Zahra-Pak Fitrat Atsa- oral mucositis manifestations with systemic drug use, Mashhad University of Medical Sciences Publications Council, 1387

    18- Sonis ST, Eilers JP, Epstein JB, ET al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Cancer 1999; 85:2103-13.

    19- Rubenstein EB, Peterson DE, Schubert M, et al. Mucositis study section of the multinational association for supportive care in cancer. International society for oral oncology. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral mucositis. Cancer 2004;100 suppl 1:2026-46.

    20- Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral oncol 1998:34(1):39.

    21-Stokman MA, Spijkervet FKI, Boezen HM, et al. Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses. J Dent Res 2006;85:690-700

    22-Bensadoun RJ, Schubert MM, Lalla RV et al. Amifostine in the management ofAmifostine in the management of radiation-induced and chemo-induced mucositis. Support Care Cancer 2006;14:566–572.

    23- Mascarin M, Franchin G, Minatel E, et al. The effect of granulocyte colony-stimulating factor on oral mucositis in head and neck cancer patients treated with hyperfractionated radiotherapy. Oral Oncol. 1999; 35:203–8.

    24- Danilenko DM. Review paper: preclinical models of psoriasis. Vet Pathol. 2008 July; 45(4):563-75.

    25-Farrell CL, Rex KL, Chen JN, Bready JV, DiPalma CR, Kaufman SA, Rattan A, Scully S, Lacey DL. The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Proliferation. 2002 August; 35 Suppl 1:78-85.

    26-Farrell CL, Bready JV, Rex KL, Chen JN, DiPalma CR, Whitcomb KL, Yin S, Hill DC, Wiemann B, Starnes CO, Havill AM, Lu ZN, Aukerman SL, Pierce GF, Thomason A, Potten CS, Ulich TR, Lacey DL. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury. mortality. Cancer Res. 1998 March 1; 58(5):933-9.

    27-Farrell CL, Rex KL, Chen JN, Bready JV, DiPalma CR, Kaufman SA, Rattan A, Scully S, Lacey DL.Cell Prolif. The effects of keratinocyte growth factor in preclinical models of mucositis. 2002 Aug;35 Suppl 1:78-85.

    28-Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T, Shea T, Yanovich S, Hansen K, Noga S, McCarty J, LeMaistre CF, Sung EC, Blazar BR, Elhardt D, Chen MG, Emmanouilides C. Palifermin. for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med. 2004 Dec 16;351(25):2590-8.

    29-Spijkervet FKL, van Saene HK, van Saene JJ, et al. Effect of selective elimination of oral flora in irradiated head and neck cancer patients. J Surg Oncol 1991;46:167-73.

    30-Barasch A, Elad S, Altman A, Damato. K, Epstein J. Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. Support Care Cancer. 2006 Jun;14(6):528-32. Epub 2006 May 4.

    31-Spijkervet FKL, van Saene HK, Panders AK, et al. The effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck who have irradiation mucositis. Oral Surg Oral Med Oral Pathol 1989;67:154-61.

    32-Samaranayake LP, Robertson AG, MacFarlane TW, Hunter IP, MacFarlane G, Soutar DS, Ferguson MM. The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation. Clin Radiol. 1988 May;39(3):291-4.

    33- Symonds RP, McIlroy P, Khorrami J, Paul J, Pyper E, Alcock SR, McCallum I, Speekenbrink AB, McMurray A, Lindemann E, Thomas M The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial. Br J Cancer.

    1996. July; 74(2):312-7.

     

    34-Epstein JP, Schubert MM. Management of orofacial pain in cancer patients. Eur J Cancer B Oral Oncol 1993; 29B:243-50.

    35-Samaranayake alp, Robertson AG, Mc farlane TW, et al. The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation. Clin Radiol 1988;39:291-4.

    36-Conger AD. Loss and recovery of taste acuity in patients irradiated to the oral cavity. Radiat Res. 1973; 53:338-47.

    37-Adams S, Toth B, Dudley Bs. Evaluation of sucralfate as a compound oral suspension for the treatment of stomatitis. Clin Pharmacol Ther 1985; 2:178.

    38-Epstein JP, Wong Fl. The efficacy of sucralfate as a compounded oral suspension for the treatment of stomatitis. J radiat Oncol Biol Phys 1994; 28:693-8.

    39- Makkonen TA, Bostr?m P, Vilja P, Joensuu H. Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study. Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):177-82.

    40-Meredith R, Salter M, Kim R, Spencer S, Weppelmann B, Rodu B, Smith J, Lee J. Sucralfate for radiation mucositis: results of a double-blind randomized trial.

Investigating the effect of propolis mouthwash in the prevention and treatment of mucosal inflammation caused by radiation therapy in head and neck cancers.